Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETFAmplify ETF Trust Amplify Weight Loss Drug & Treatment ETFAmplify ETF Trust Amplify Weight Loss Drug & Treatment ETF

Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF

Inga transaktioner
Se i superdiagram

Nyckeltal

Assets under management (AUM)
‪3.14 M‬USD
Fund flows (1Y)
Dividend yield (indicated)
Discount/Premium to NAV
−0.2%

Om Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF

Issuer
Amplify Holding Co. LLC
Brand
Amplify
Expense ratio
0.59%
Inception date
21 maj 2024
Index tracked
VettaFi Weight Loss Drug Index - Benchmark TR Net
Management style
Passive

Classification

Asset Class
Equity
Kategori
Sektor
Focus
Sjukvård
Niche
Läkemedel, bioteknik och biovetenskap
Strategi
Vanilj
Weighting scheme
Tiered
Selection criteria
Börsvärde

Returns

1 månad3 månaderHittills i år1 år3 år5 år
Price performance
NAV total return

What's in the fund

As of 27 juni 2024
Exposure type
AktierBonds, Cash & Other
Hälsoteknik
Aktier99.53%
Hälsoteknik90.28%
Processindustrier3.56%
Kommersiella tjänster2.01%
Hälsotjänster0.83%
Bonds, Cash & Other0.47%
Andelsfond3.41%
Likvida medel−2.94%
Stock breakdown by region
69%13%16%
Nordamerika69.95%
Asien16.30%
Europa13.75%
Latinamerika0.00%
Afrika0.00%
Mellanöstern0.00%
Oceanien0.00%
Top 10 holdings

Utdelningar

Utdelningshistorik

Assets under management (AUM)

Fund Flows